Genetic Factors

Genetic factors mainly include genes, mutations, family history, etc.
The search result for the Risk factor Category "Genetic"
A total of 885 results found based on your keywords
RF_ID Disease Name Species RF_Name Association Condition PMID
1 Alzheimer's disease human 5, 10-methylenetetrahydrofolate dehydrogenase gene (MTHFD1) RF 20217437
2 Alzheimer’s Disease human 5-HTT RF homozygous low activity genotype: ε4 alleles of the ApoE gene 9106747
3 Alzheimer's Disease human 5-LO RF A allele 20110601
4 Amyotrophic Lateral Sclerosis human A90V TDP-43 variant RF 18505686
5 Alzheimer’s Disease human ABCA7 RF Calculated by fixed effect model 29504051
5 Alzheimer’s Disease human ABCA7 RF 29589097
5 Alzheimer’s Disease human ABCA7 RF 29589097
5 Alzheimer’s Disease human ABCA7 RF 29589097
5 Alzheimer’s Disease human ABCA7 PF National Alzheimer’s Coordinating Center (NACC) cohort 30128317
5 Alzheimer's disease human ABCA7 RF 26795201
5 Alzheimer's disease human ABCA7 RF with both ApoEε4-carrier and aging being factors enhancing its risk 24113560
6 Parkinson's Disease human ABCB1 RF 24572589
7 Alzheimer’s Disease human ACE RF 11078932
7 Alzheimer's Disease human ACE RF 21537449
7 Parkinson's Disease human ACE RF 12084438
7 Parkinson's Disease human ACE RF 12084438
7 Alzheimer's Disease human ACE RF in subjects aged 73 years and above. 19539712
7 Alzheimer's Disease human ACE RF in subjects aged 73 years and above. 19539712
8 Alzheimer's disease human ACT RF especially in Caucasians 22294107
8 Alzheimer's disease human ACT RF especially in Caucasians 22294107
8 Alzheimer's disease human ACT RF A allele carriers are associated with increased susceptibility to AD in variant populations 22272609
8 Alzheimer's disease human ACT RF A allele carriers are associated with increased susceptibility to AD in variant populations 22272609
8 Multiple System Atrophy human ACT RF 15907346
9 Parkinson's Disease human ADH1B RF 30483881
10 Alzheimer's disease human ALDH2 RF dependent on APOE epsilon4 status in Chinese 18201725
11 Alzheimer's disease human ALOX5 RF 26944113
12 Alzheimer's disease human ANK1 RF 26611832
13 Alzheimer's Disease human APOC1 RF using logistic regression、Dataset：FHS(Framingham Heart Study) 29107063
13 Alzheimer's Disease human APOC1 RF using Cox regression、Dataset：CHS（Cardiovascular Health Study） 29107063
13 Alzheimer's Disease human APOC1 RF using Cox regression、Dataset：FHS（Framingham Heart Study） 29107063
13 Alzheimer's disease human APOC1 RF 30443289
13 Alzheimer's disease human APOC1 RF not in African Americans 24498013
14 Alzheimer's Disease human APOD RF in APOEε4 (-) subgroup 23690001
15 Alzheimer's Disease human APOE RF 22712640
15 Lewy body dementia human APOE RF 12411758
15 Alzheimer’s Disease human APOE RF ε4 allele 29990559
15 Alzheimer’s Disease human APOE PF ε2 allele 29990559
15 Alzheimer’s Disease human APOE PF ε3 allele 29990559
15 Alzheimer’s Disease human APOE RF Genotype/Allele: A/A 29990559
15 Alzheimer’s Disease human APOE PF Genotype/Allele: A/T 29990559
15 Alzheimer’s Disease human APOE RF Genotype/Allele: A 29990559
15 Alzheimer’s Disease human APOE PF Genotype/Allele: T 29990559
15 Alzheimer’s Disease human APOE RF ε4 allele 29592889
15 Alzheimer’s Disease human APOE RF ε4 allele 30112972
15 Alzheimer’s Disease human APOE RF ε4 allele; AD all 29703883
15 Alzheimer’s Disease human APOE RF ε4 allele; AD without depression 29703883
15 Alzheimer’s Disease human APOE RF Genotype: ?3/?4; AD all 29703883
15 Alzheimer’s Disease human APOE RF Genotype: ?3/?4; AD without depression 29703883
15 Alzheimer’s Disease human APOE RF Genotype: ?4/?4; AD without depression 29703883
15 Alzheimer’s Disease human APOE RF PENN cohort; ε2 30128317
15 Alzheimer’s Disease human APOE PF PENN cohort; ε4 30128317
15 Alzheimer’s Disease human APOE RF National Alzheimer’s Coordinating Center (NACC) cohort; ε2 30128317
15 Alzheimer’s Disease human APOE PF National Alzheimer’s Coordinating Center (NACC) cohort; ε4 30128317
15 Alzheimer’s Disease human APOE RF ε4 allele 7841371
15 Alzheimer’s Disease human APOE RF ε2 allele 7824157
15 Alzheimer’s Disease human APOE RF ε2 allele 29562509
15 Alzheimer’s Disease human APOE RF Genotype: ε3/4; adjusted for age and education, and stratified by gender 30205398
15 Alzheimer’s Disease human APOE RF Genotype: ε4/4; adjusted for age and education, and stratified by gender 30205398
15 Alzheimer’s Disease human APOE RF Genotype: ε4/-; adjusted for age and education, and stratified by gender 30205398
15 Alzheimer’s Disease human APOE RF Genotype: ε3/4; adjusted for age and education, and stratified by gender 30205398
15 Alzheimer’s Disease human APOE RF Genotype: ε4/-; adjusted for age and education, and stratified by gender 30205398
15 Alzheimer’s Disease human APOE RF Genotype: ε3/4; adjusted for age and education, and stratified by gender 30205398
15 Alzheimer’s Disease human APOE RF Genotype: ε4/4; adjusted for age and education, and stratified by gender 30205398
15 Alzheimer’s Disease human APOE RF Genotype: ε4/-; adjusted for age and education, and stratified by gender 30205398
15 Alzheimer’s Disease human APOE RF ε4 allele; stronger in women 30039745
15 Alzheimer’s Disease human APOE RF ε4 allele 7977635
15 Alzheimer’s Disease human APOE RF ε4 allele; associated with homozygosity 8128961
15 Alzheimer’s Disease human APOE RF ε4 allele; associated with heterozygosity 8128961
15 Alzheimer’s Disease human APOE RF at least one epsilon 4 allele 8786847
15 Alzheimer’s Disease human APOE RF Genotype: AA 10213175
15 Alzheimer’s Disease human APOE RF Carrying at least one ε4 allele 10213175
15 Alzheimer’s Disease human APOE RF Gender: female; Calculated by Step-wise model 10213175
15 Alzheimer’s Disease human APOE RF Carrying at least one ε4 allele; Calculated by Step-wise model 10213175
15 Alzheimer’s Disease human APOE RF Gender: female; Calculated by Forced entry model 10213175
15 Alzheimer’s Disease human APOE RF Carrying at least one ε4 allele; Calculated by Forced entry model 10213175
15 Alzheimer’s Disease human APOE RF 9008509
15 Alzheimer’s Disease human APOE RF 8993485
15 Alzheimer’s Disease human APOE RF 9811931
15 Alzheimer’s Disease human APOE RF ε4 allele 11376902
15 Alzheimer’s Disease human APOE RF ε4 allele 12160362
15 Alzheimer’s Disease human APOE RF 12095653
15 Alzheimer’s Disease human APOE RF 12095653
15 Alzheimer’s Disease human APOE RF Th1/E47cs polymorphism allele 12095653
15 Alzheimer’s Disease human APOE RF APOE ε4 10912224
15 Alzheimer's Disease human APOE RF using logistic regression、Dataset：CHS( Cardiovascular Health Study) 29107063
15 Alzheimer's Disease human APOE RF using logistic regression、Dataset：HRS(Health and Retirement Study) 29107063
15 Alzheimer's Disease human APOE RF using logistic regression、Dataset：LOADFS(Late Onset Alzheimer's Disease Family Study ) 29107063
15 Alzheimer's Disease human APOE RF using Cox regression、Dataset：CHS（Cardiovascular Health Study） 29107063
15 Alzheimer's Disease human APOE RF using Cox regression、Dataset：HRS（Health and Retirement Study） 29107063
15 Alzheimer's Disease human APOE PF APOEε2ε3 25673977
15 Alzheimer's Disease human APOE RF APOE ε3ε4 25673977
15 Alzheimer's Disease human APOE RF APOE ε4ε4 25673977
15 Alzheimer's Disease human APOE RF A/A genotype 19172988
15 Alzheimer's disease human APOE RF 30991302
15 Alzheimer's disease human APOE RF 30894904
15 Alzheimer's disease human APOE RF 30890475
15 Alzheimer's disease human APOE RF 30450407
15 Alzheimer's disease human APOE RF 28461186
15 Alzheimer's disease human APOE RF 27079723
15 Alzheimer's disease human APOE RF 27033052
15 Alzheimer's disease human APOE RF 26885125
15 Alzheimer's disease human APOE RF The ε4 allele increases the risk of Alzheimer's disease by 5.114 times 26835020
15 Alzheimer's disease human APOE RF 26738348
15 Alzheimer's disease human APOE RF 24326531
15 Alzheimer's disease human APOE RF 24281128
15 Alzheimer's disease human APOE RF 24045327
15 Alzheimer's disease human APOE RF 23887281
15 Alzheimer's disease human APOE RF 23871727
15 Alzheimer's disease human APOE RF 23871727
15 Alzheimer's disease human APOE RF 22311091
15 Alzheimer's disease human APOE PF 22068907
15 Alzheimer's disease human APOE RF 22068907
15 Alzheimer's disease human APOE RF 21649613
15 Alzheimer's disease human APOE RF 21637534
15 Alzheimer's disease human APOE RF 21556001
15 Alzheimer's disease human APOE RF The rate of APOE4 carrier status and the frequency of the ε4 allele were 47% and 27% for LOAD, 50% and 31% for EOAD, 21552550
15 Alzheimer's disease human APOE RF 22737475
15 Alzheimer's disease human APOE RF 20682755
15 Alzheimer's disease human and mice APOE RF nutritional imbalance 20413864
15 Alzheimer's disease human APOE RF 20385913
15 Alzheimer's disease human APOE RF 20376800
15 Alzheimer's disease human APOE RF 20217437
15 Alzheimer's disease human APOE RF 18560129
15 Alzheimer's disease human APOE RF 18446027
15 Alzheimer's disease human APOE RF lowers age at onset of LOAD significantly 18416843
15 Alzheimer's disease human APOE RF Individuals with 2 epsilon 4 alleles had a higher risk for AD than subjects with only 1 such allele 18317248
15 Alzheimer's disease human APOE PF 18317248
15 Alzheimer's disease human APOE RF 18317248
15 Alzheimer's disease human APOE PF 18317248
15 Creutzfeldt-Jakob disease human APOE RF ε4 allele 7968026
15 Creutzfeldt-Jakob disease human APOE RF ε4 allele 7968026
15 Creutzfeldt-Jakob disease human APOE RF ε4 allele 7968026
15 Frontotemporal Dementia human APOE RF 23887281
15 Frontotemporal Lobar Degeneration human APOE RF ε4 vs. ε3 allele model 28487499
15 Frontotemporal Lobar Degeneration human APOE RF ε4 vs. ε2 allele model 28487499
15 Frontotemporal Lobar Degeneration human APOE RF ε4 vs. ε2+ε3+ε4 allele model 28487499
15 Frontotemporal Lobar Degeneration human APOE RF ε4 vs. ε2+ε3+ε4 carrier model 28487499
15 Frontotemporal Lobar Degeneration human APOE RF ε4ε4 vs. ε3ε3 28487499
15 Frontotemporal Lobar Degeneration human APOE RF ε3ε4 vs. ε3ε3 28487499
15 Frontotemporal Lobar Degeneration human APOE RF ε3ε4+ε4ε4 vs. ε3ε3 28487499
15 Frontotemporal Lobar Degeneration human APOE RF ε4ε4 vs. ε3ε3+ε3ε4 28487499
15 Frontotemporal Lobar Degeneration human APOE RF ε2ε2 vs. ε3ε3 28487499
15 Frontotemporal Lobar Degeneration human APOE RF ε2ε2 vs. ε3ε3+ε3ε2 28487499
15 Frontotemporal Lobar Degeneration human APOE RF ε4 allele 15904995
15 Frontotemporal Lobar Degeneration human APOE PF ε2 allele 15904995
15 Frontotemporal Lobar Degeneration human APOE RF ε4 allele 23887281
15 Lewy body dementia human APOE RF 29263008
15 Lewy body dementia human APOE RF 24973356
15 Lewy body dementia human APOE RF 4 allele 16956959
15 Lewy body dementia human ApoE RF epsilon 4 allele 7970234
15 Lewy body dementia human APOE RF The rate of APOE4 carrier status and the frequency of the ε4 allele were 42% and 31% for DLB 21552550
15 Alzheimer's Disease human APOE RF APOE haplotypes 24596166
15 Alzheimer's Disease human ApoE RF ?4 allele 23038715
15 Frontotemporal Dementia human APOE PF 12107813
15 Frontotemporal Dementia human APOE PF 15904995
15 Frontotemporal Dementia human APOE RF 15904995
15 Alzheimer's Disease human APOE RF 19819468
15 progressive supranuclear palsy human APOE RF 12552038
15 Frontotemporal Dementia human APOE RF 28888721
15 Lewy body dementia human APOE PF 30798004
16 Alzheimer's Disease human APOE ε2/ε3 PF 28846757
16 Alzheimer's Disease human APOE ε2/ε3 PF 28846757
15 Alzheimer's Disease human APOE PF ε3 allele 24632849
17 Alzheimer's Disease human APOE ε3/ε4 RF from ages 55 to 85 years 28846757
17 Alzheimer's Disease human APOE ε3/ε4 RF from ages 55 to 85 years 28846757
15 Alzheimer's Disease human APOE RF 29348964
15 Alzheimer's Disease human APOE RF 25853819
15 Alzheimer's Disease human APOE RF ε4 allele 24632849
15 Frontotemporal Dementia human APOE PF 28888721
15 Lewy body dementia human APOE RF 30798004
15 Lewy body dementia human APOE RF 27312774
15 Frontotemporal Dementia human APOE RF 23887281
18 Alzheimer's Disease human ApoE ε4/ε3 RF ε4/ε3 genotype 24632849
19 Alzheimer's Disease human ApoE ε4/ε4 RF ε4/ε4 genotype 24632849
20 Alzheimer’s Disease human APOE,ACT RF ACT Genotype: TT; One Copy of ε4 8993481
20 Alzheimer’s Disease human APOE,ACT RF ACT Genotype: TT; Two Copies of ε4 8993481
20 Alzheimer’s Disease human APOE,ACT RF ACT Genotype: AT; One Copy of ε4 8993481
20 Alzheimer’s Disease human APOE,ACT RF ACT Genotype: AT; Two Copies of ε4 8993481
20 Alzheimer’s Disease human APOE,ACT RF ACT Genotype: AA; One Copy of ε4 8993481
20 Alzheimer’s Disease human APOE,ACT RF ACT Genotype: AA; Two Copies of ε4 8993481
21 Frontotemporal Lobar Degeneration human APOE,TOMM40 RF APOE-TOMM40 haplotype: ε4 GAC 23546992
22 Amyotrophic Lateral Sclerosis human APOE-2 PF 15657798
15 Alzheimer's Disease human APOE RF 29307083
23 Lewy body dementia human APP RF 27312774
24 Alzheimer's Disease human Arg972 IRS1 RF AA genotype 24589556
24 Alzheimer's Disease human Arg972 IRS1 RF GA genotype 24589556
24 Alzheimer's Disease human Arg972 IRS1 RF A Allele 24589556
25 Alzheimer's Disease human ASTN2 RF 25410587
26 Amyotrophic Lateral Sclerosis human ATAXIN2 RF ≥ 31 CAG-repeat length 22425256
27 Alzheimer's Disease human ATP10B RF 22950421
28 Alzheimer's Disease human ATP7B RF 22950421
29 Alzheimer's Disease human ATP8B RF 22950421
30 Alzheimer's Disease human ATP9B RF 22950421
31 Amyotrophic lateral sclerosis human ATRN RF 27455347
32 Amyotrophic lateral sclerosis human ATXN1 RF 25023141
33 Amyotrophic lateral sclerosis human ATXN2 RF 30847648
33 Amyotrophic lateral sclerosis human ATXN2 RF 26208502
33 Amyotrophic lateral sclerosis human ATXN2 RF 23197749
33 Amyotrophic Lateral Sclerosis human ATXN2 RF ATXN2 polyQ repeat expansions greater than 27 21741123
33 Amyotrophic Lateral Sclerosis human ATXN2 RF ATXN2 high-length alleles (≥29 CAG repeats) 21670397
33 Amyotrophic Lateral Sclerosis human ATXN2 RF ATXN2 high-length alleles (≥29 CAG repeats) 21670397
33 Frontotemporal Dementia human ATXN2 RF ATXN2 intermediary polyQ expansions 25098532
33 Frontotemporal Lobar Degeneration human ATXN2 RF ATXN2 intermediary repeat length>=29 25098532
34 Alzheimer's disease human BACE1 RF with APOEε4 carrier status 26550136
34 Alzheimer's disease human BACE1 RF in carrying the ApoE epsilon4 allele 18182766
35 Alzheimer's disease human BACE2 RF Rheumatoid arthritis (RA) RA-SNPs Association with AD 21595938
36 Alzheimer's Disease human BDNF C270T RF 26136901
37 Alzheimer’s Disease human BIN1 RF Calculated by fixed effect model 29504051
37 Alzheimer’s Disease human BIN1 RF Calculated by random effect model 29504051
37 Alzheimer’s Disease human BIN1 RF Calculated by fixed effect model 29504051
37 Alzheimer’s Disease human BIN1 RF Calculated by random effect model 29504051
37 Alzheimer’s Disease human BIN1 RF Calculated by fixed effect model 29504051
37 Alzheimer’s Disease human BIN1 PF National Alzheimer’s Coordinating Center (NACC) cohort 30128317
37 Alzheimer’s Disease human BIN1 PF National Alzheimer’s Coordinating Center (NACC) cohort 30128317
37 Alzheimer's disease human BIN1 RF 26768592
37 Alzheimer's disease human BIN1 RF 26768592
38 Amyotrophic lateral sclerosis human BIRC6 RF 27455347
39 Frontotemporal Lobar Degeneration human C17orf89 RF Minor allele:C 26154020
40 Amyotrophic lateral sclerosis human C1QTNF7 RF 27455347
41 Alzheimer's Disease human C282Y HFE PF 19429178
42 Frontotemporal Lobar Degeneration human C4orf27 RF Discovery stage 30739198
43 Amyotrophic lateral sclerosis human C7orf57 RF 25023141
44 Amyotrophic lateral sclerosis human C9orf72 RF 25023141
44 Amyotrophic lateral sclerosis human C9orf72 RF 29528390
44 Amyotrophic Lateral Sclerosis human C9orf72 RF 20801718
44 Frontotemporal Lobar Degeneration human C9orf72 RF C9orf72 repeat expansions; All FTD patients with mutations had a positive family history for dementia or ALS 25108559
44 Parkinson's Disease human C9ORF72 RF 23845100
45 Alzheimer's Disease human CALHM1 RF 20061624
45 Creutzfeldt-Jakob disease human CALHM1 RF Genotype:GG 22874670
45 Creutzfeldt-Jakob disease human CALHM1 PF 22874670
46 Parkinson's Disease human CARD15 RF 17174426
47 Parkinson's Disease human CCDC62/HIP1R RF 25818163
48 Parkinson's Disease human CCL2 RF 30761072
48 Parkinson's Disease human CCL2 RF 30761072
49 Parkinson's Disease human CD14 RF 16337421
50 Parkinson's Disease rat CD157/BST1 RF 24795584
51 Alzheimer's Disease human CD163L1 RF 29177109
52 Alzheimer's disease human CD33 PF this association was not significant in Asians 26795201
52 Alzheimer's disease human CD33 RF 22382309
52 Alzheimer's disease human CD33 PF in APOE e4 carriers 22167654
52 Alzheimer's disease human CD33 PF in APOE e4 carriers 22167654
53 Alzheimer’s Disease human CD36 RF Genotype: GG 30235742
53 Alzheimer’s Disease human CD36 RF Genotype: GG; Adjusting the physiological and biochemical factors, including age, FBG, BMI, SBP, DBP, HDLC [According to univariate analysis, there was a significant deviation (P<0.05)]. 30235742
53 Alzheimer’s Disease human CD36 RF Genotype: Dominant 30235742
53 Alzheimer’s Disease human CD36 RF Genotype: Dominant; Adjusting the physiological and biochemical factors, including age, FBG, BMI, SBP, DBP, HDLC [According to univariate analysis, there was a significant deviation (P<0.05)]. 30235742
53 Alzheimer’s Disease human CD36 RF Genotype: Recessive 30235742
53 Alzheimer’s Disease human CD36 PF Genotype: GT 30235742
53 Alzheimer’s Disease human CD36 PF Genotype: GT; Adjusting the physiological and biochemical factors, including age, FBG, BMI, SBP, DBP, HDLC [According to univariate analysis, there was a significant deviation (P<0.05)]. 30235742
53 Alzheimer’s Disease human CD36 PF Genotype: Dominant 30235742
53 Alzheimer’s Disease human CD36 PF Genotype: Dominant; Adjusting the physiological and biochemical factors, including age, FBG, BMI, SBP, DBP, HDLC [According to univariate analysis, there was a significant deviation (P<0.05)]. 30235742
54 Alzheimer's Disease human CDK5RAP2 RF 29360470
54 Alzheimer's Disease human CDK5RAP2 PF for female AA carriers 29360470
55 Frontotemporal Lobar Degeneration human CEP131 RF Minor allele:T 26154020
55 Frontotemporal Lobar Degeneration human CEP131 RF Minor allele:T 26154020
55 Frontotemporal Lobar Degeneration human CEP131 RF Minor allele:A 26154020
55 Frontotemporal Lobar Degeneration human CEP131 RF Minor allele:A 26154020
55 Frontotemporal Lobar Degeneration human CEP131 RF Minor allele:C 26154020
56 Alzheimer's disease human CHAT RF 27272392
56 Alzheimer's disease human CHAT RF 27272392
56 Alzheimer's disease human CHAT RF 18562794
57 Lewy body dementia human CHCHD2 RF 26561290
57 Parkinson's Disease human CHCHD2 RF 27626775
58 Amyotrophic Lateral Sclerosis human CHGB RF 20007371
58 Amyotrophic Lateral Sclerosis human CHGB RF 20007371
59 Alzheimer’s Disease human CHI3L1 PF CG+GG 30223258
59 Alzheimer’s Disease human CHI3L1 PF G allele 30223258
59 Alzheimer’s Disease human CHI3L1 RF TT 30223258
59 Alzheimer’s Disease human CHI3L1 RF CT+TT 30223258
59 Alzheimer’s Disease human CHI3L1 RF T allele 30223258
60 Creutzfeldt-Jakob disease human CHN2 RF 22210626
61 Amyotrophic lateral sclerosis human CHRNA4 RF 22873564
62 Alzheimer's disease human chromosome 12q24.22 RF 24361131
63 Multiple System Atrophy human chromosome 22 RF 29187220
63 Multiple System Atrophy human chromosome 22 RF 29187220
64 Multiple System Atrophy human chromosome 4 RF 29187220
64 Multiple System Atrophy human chromosome 4 RF 29187220
64 Multiple System Atrophy human chromosome 4 RF 29187220
64 Multiple System Atrophy human chromosome 4 RF 29187220
64 Multiple System Atrophy human chromosome 4 RF 29187220
65 Multiple System Atrophy human chromosome 5 RF 29187220
65 Multiple System Atrophy human chromosome 5 RF 29187220
66 Alzheimer's disease human chromosome 9p21.3 RF 20427016
66 Alzheimer's disease human chromosome 9p21.3 RF in non-APOE epsilon4 20427016
66 Alzheimer's Disease human Chromosome 9p21.3 RF C allele 19664850
67 Alzheimer's Disease human CLECL1 RF 29177109
68 Alzheimer’s Disease human CLU RF Calculated by fixed effect model 29504051
68 Alzheimer’s Disease human CLU RF Calculated by fixed effect model 29504051
68 Alzheimer’s Disease human CLU RF Calculated by fixed effect model 29504051
68 Alzheimer’s Disease human CLU RF Calculated by random effect model 29504051
68 Alzheimer's disease human CLU RF 26757186
68 Alzheimer's disease human CLU PF 26757186
69 Lewy body dementia human CNTN1 RF 29263008
70 Parkinson's Disease human COMT PF not Caucasian populations 23466833
70 Parkinson's Disease human COMT PF not Caucasian populations 23466833
70 Parkinson's Disease human COMT RF not Caucasian populations 23466833
70 Parkinson's Disease human COMT RF 9503277
71 Alzheimer's Disease human COMT Met allele RF without APOE ε4 allele carriers 24575113
71 Alzheimer's Disease human COMT Met allele RF without APOE ε4 allele carriers;in men 24575113
72 Multiple System Atrophy human COQ2 RF 27123473
73 Alzheimer's Disease human COX-2 RF GG allele 20110601
73 Alzheimer's Disease human COX-2 RF G allele 20110601
74 Alzheimer’s Disease human CR1 RF Calculated by fixed effect model 29504051
74 Alzheimer’s Disease human CR1 RF Calculated by fixed effect model 29504051
74 Alzheimer’s Disease human CR1 RF Calculated by fixed effect model 29504051
74 Alzheimer’s Disease human CR1 PF PENN cohort 30128317
74 Alzheimer’s Disease human CR1 PF National Alzheimer’s Coordinating Center (NACC) cohort 30128317
75 Amyotrophic lateral sclerosis human CREB3L2 RF 27455347
76 Alzheimer’s Disease human CST3 RF CST3-A allele; APOE ε4 carrier 11711204
76 Alzheimer’s Disease human CST3 RF CST3-A allele; Non-APOE ε4 carrier 11711204
76 Alzheimer’s Disease human CST3 RF Caucasians 10993992
76 Frontotemporal Lobar Degeneration human CST3 RF negative for the presence of PGRN mutations;haplotype B 19674067
76 Frontotemporal Lobar Degeneration human CST3 RF negative for the presence of PGRN mutations;AB/BB genotypes 19674067
77 Alzheimer's Disease human CTNNA1 RF 29177109
78 Alzheimer's disease human CTSD RF 24281128
78 Creutzfeldt-Jakob disease human CTSD RF Genotype:CC 18426579
78 Creutzfeldt-Jakob disease human CTSD RF Genotype:CT 18426579
79 Amyotrophic lateral sclerosis human CX3CR1 RF 24806473
79 Amyotrophic lateral sclerosis human CX3CR1 RF 24806473
79 Amyotrophic lateral sclerosis human CX3CR1 RF 24806473
80 Alzheimer's disease human CYP17A1 PF in APOE e4 carriers 26940238
80 Alzheimer's disease human CYP17A1 RF in APOE e4 carriers 26940238
81 Alzheimer's disease human CYP19A1 RF 27583919
82 Alzheimer’s Disease human CYP2D6 RF CYP2D6B allele; in the Lewy body variant of AD 7818242
83 Alzheimer's Disease human CYP2J2 RF total;Allele T 25796175
83 Alzheimer's Disease human CYP2J2 RF total;Genotype GT + TT 25796175
84 Alzheimer’s Disease human CYP46A1 RF Overall; Genotype:TC; logistic regression model 29516283
84 Alzheimer’s Disease human CYP46A1 RF APOE ε4 carrier; Genotype:CC 29516283
84 Alzheimer’s Disease human CYP46A1 RF Overall; Genotype:TT; dominant mode 29516283
84 Alzheimer’s Disease human CYP46A1 RF APOE ε4 carrier; Genotype:TT; dominant mode 29516283
84 Alzheimer’s Disease human CYP46A1 RF APOE ε4 carrier; Genotype:CC; additive model 29516283
84 Alzheimer’s Disease human CYP46A1 RF APOE ε3/ε4; Genotype:TT; dominant mode 29516283
84 Alzheimer’s Disease human CYP46A1 RF APOE ε3/ε4; Genotype:CC; additive model 29516283
84 Alzheimer's Disease human CYP46A1 RF CYP46A1 gene variations 19286353
84 Alzheimer's disease human CYP46A1 RF 22528464
85 Alzheimer's disease human DAPK1 PF especially the homozygotes 21167819
85 Alzheimer's disease human DAPK1 RF 21167819
86 Amyotrophic lateral sclerosis human DCC RF 27455347
87 Frontotemporal Lobar Degeneration human DCUN1D1 RF Genotype:GG 19473369
88 Parkinson's Disease human DGCR8 RF 24018986
88 Parkinson's Disease human DGCR8 RF 24018986
89 Amyotrophic lateral sclerosis human DISC1 RF 25023141
90 Parkinson's Disease human DMT1 RF 25817364
90 Parkinson's Disease human DMT1 RF 21777657
91 Amyotrophic lateral sclerosis human DPP6 RF 25023141
91 Frontotemporal Lobar Degeneration human DPP6 RF Discovery stage 30739198
91 Frontotemporal Lobar Degeneration human DPP6 RF Discovery stage 30739198
92 Amyotrophic lateral sclerosis human DPYSL3(CRMP4) RF 23568759
93 Alzheimer's Disease human DR4 PF the GA genotype 25207117
93 Alzheimer's Disease human DR4 RF GCA haplotype 25207117
93 Alzheimer's Disease human DR4 RF GCC haplotype 25207117
93 Alzheimer's Disease human DR4 PF ACA haplotype 25207117
93 Alzheimer's Disease human DR4 PF GGC haplotype 25207117
93 Alzheimer's Disease human DR4 PF GGA haplotype 25207117
94 Tourette Syndrome human DRD2 RF 20431429
95 progressive supranuclear palsy human DUSP10 PF Meta-analysis 29986742
96 Parkinson's Disease human DYRK1A RF especially for males 27546826
97 progressive supranuclear palsy human EIF2AK3 PF Meta-analysis 29986742
98 Parkinson's Disease human EMTP variation RF 30675927
99 Alzheimer's Disease human ENST00000414107 RF 29027019
100 Frontotemporal Lobar Degeneration human ENTHD2 RF Minor allele:G 26154020
101 Amyotrophic lateral sclerosis human ERp57/PDIA3 RF 25913742
102 Alzheimer's disease human ESR1 RF 20674091
102 Alzheimer's disease human ESR1 PF 20674091
102 Alzheimer's disease human ESR1 RF 20674091
103 Alzheimer's disease human ESR1 and ESR2 RF the genetic profile created with the combination of the less represented alleles of these SNPs (expressed as XPAA) 24052609
104 Alzheimer's disease human ESR2 RF predominantly Caucasian AIMS-defined ancestry 24326520
104 Alzheimer's disease human ESR2 RF predominantly Caucasian AIMS-defined ancestry 24326520
104 Alzheimer's disease human ESR2 RF predominantly Caucasian AIMS-defined ancestry 24326520
104 Alzheimer's disease human ESR2 RF predominantly Caucasian AIMS-defined ancestry 24326520
105 Alzheimer's disease human ESR3 PF 24326520
106 Alzheimer's disease human EXOC3L2 RF 28423615
106 Alzheimer's disease human EXOC3L2 PF 28423615
107 Parkinson's Disease human Famliy history of familial Parkinson's disease RF 21059511
107 Parkinson's Disease human Famliy history of familial Parkinson's disease RF 8771062
108 Parkinson's Disease human FGF20 RF 26070653
108 Parkinson's Disease human FGF20 RF 26070653
108 Parkinson's Disease human FGF20 RF 24942208
108 Parkinson's Disease human FGF20 RF 22342445
108 Parkinson's Disease human FGF20 RF 15122513
108 Parkinson's Disease human FGF20 RF 15122513
109 Alzheimer's disease human FRMD4A RF 22430674
110 Amyotrophic lateral sclerosis human FUS RF 28054830
111 Alzheimer's Disease human G-308A( TNF-alpha gene) RF A-allele 18992723
112 Alzheimer's Disease human GAB2 RF ApoE epsilon4 non-carriers 19276544
112 Alzheimer's disease human GAB2 PF 26770425
112 Alzheimer's disease human GAB2 PF 26770425
112 Alzheimer's disease human GAB2 RF 21285854
112 Alzheimer's disease human GAB2 RF 21285854
112 Alzheimer's disease human GAB2 RF 21285854
112 Alzheimer's disease human GAB2 RF 21285854
112 Alzheimer's disease human GAB2 RF 21108942
112 Alzheimer's disease human GAB2 RF a minor genetic determinant of AD 18272374
113 Alzheimer's Disease human GALR3 RF 29177109
114 Amyotrophic lateral sclerosis human GARS RF 30661401
115 Lewy body dementia human GBA RF 29263008
115 Lewy body dementia human GBA RF 27723861
115 Lewy body dementia human GBA RF 27312774
115 Lewy body dementia human GBA RF 27027900
115 Parkinson's Disease human GBA RF Patients with early-onset were more likely to carry GBA mutations than those with late-onset 26868973
115 Parkinson's Disease human GBA RF strong risk factors in FPD, especially for autosomal dominant PD 24126159
115 Parkinson's Disease human GBA RF 24997549
115 Parkinson's Disease human GBA RF 22812582
115 Parkinson's Disease human GBA RF 22387070
115 Parkinson's Disease human GBA RF 20131388
115 Parkinson's Disease human GBA RF 17702778
115 Parkinson's Disease human GBA RF 26000814
115 Parkinson's Disease human GBA RF 30765263
115 Parkinson's Disease human GBA RF 30765263
115 Parkinson's Disease human GBA RF 30765263
115 Lewy body dementia human GBA RF 18332251
116 Lewy body dementia human GBA1 RF 23588557
116 Parkinson's Disease human GBA1 RF non-N370S mutations associated with Gaucher disease 22968580
117 Alzheimer's Disease human GCH1 RF 29432188
117 Parkinson's Disease human GCH1 RF 27871051
118 Parkinson's Disease human GLIS1 RF 22759478
119 Alzheimer's disease human GOLPH2 RF 22167654
119 Alzheimer's disease human GOLPH2 RF 22167654
120 Parkinson's Disease human GRIN2A RF taking creatine who also have high levels of caffeine intake 28320167
121 Parkinson's Disease human GRIN2A T allele RF taking creatine who also have high levels of caffeine intake 28320167
122 Alzheimer's disease human GRN RF 26820675
122 Frontotemporal Lobar Degeneration human GRN RF 24503614
122 Frontotemporal Lobar Degeneration human GRN RF Genotype:TT 18723524
122 Frontotemporal Lobar Degeneration human GRN RF more common (T) allele 20154673
123 Alzheimer's disease human GSTM1 RF 22381228
123 Alzheimer's Disease human GSTM1 RF 29072550
124 Alzheimer's disease human GSTO1 RF 22100662
125 Alzheimer's disease human GSTP1 RF mainly in the presence of the apoE 4 allele 18298341
126 Alzheimer's Disease human GSTT1 RF 22813660
126 Alzheimer's Disease human GSTT1 RF 29072550
127 Alzheimer's disease human hemochromatosis (HFE) RF 27081498
128 Parkinson's Disease human HFE PF Australian PD patients 12098643
128 Parkinson's Disease human HFE PF Australian PD patients 12098643
128 Parkinson's Disease human HFE RF 16824219
128 Parkinson's Disease human HFE RF 16824219
128 Amyotrophic Lateral Sclerosis human HFE RF Genotype:GC 20642794
128 Amyotrophic Lateral Sclerosis human HFE RF Genotype:GC/GG 20642794
128 Amyotrophic Lateral Sclerosis human HFE RF Genotype:G allele frequency 20642794
129 Alzheimer’s Disease human HIF3A RF eQTL(expression quantitative trait loci) analysis for the five SNPs closely related to AD 30319691
130 Alzheimer's Disease human HLA-A24 RF 18936542
131 Frontotemporal Lobar Degeneration human HLA-DQA2 RF Discovery stage 30739198
131 Frontotemporal Lobar Degeneration human HLA-DQA2 RF Replication stage 30739198
132 Parkinson's Disease human HLA-DRA RF 25319953
133 Amyotrophic Lateral Sclerosis human HLA-DRA/HLA-DRB5 RF the AA genotype at rs9268856 28131168
134 Alzheimer's Disease human HLA-DRB1 RF under a recessive model in the total sample 29190991
134 Alzheimer's Disease human HLA-DRB1 RF non-APOE ε4 carriers with rs9271192 genotype CC;additive model 29190991
134 Alzheimer's Disease human HLA-DRB1 RF non-APOE ε4 carriers with rs9271192 genotype CC;recessive model 29190991
135 Frontotemporal Lobar Degeneration human HMCN1 PF Discovery stage 30739198
136 Frontotemporal Lobar Degeneration human hnRNP-A1 RF C/C genotype 21548758
136 Frontotemporal Lobar Degeneration human hnRNP-A1 RF C/C genotype 21548758
137 Alzheimer’s Disease human HSP70/HSPA1A PF Genotype: A/C; AD without depression 29703883
138 Alzheimer's Disease human IL-1 beta promoter polymorphism RF APOE4 presence:No stratified 18717723
138 Alzheimer's Disease human IL-1 beta promoter polymorphism RF APOE4 presence:APOE4 yes 18717723
138 Alzheimer's Disease human IL-1 beta promoter polymorphism RF APOE4 presence:APOE4 no 18717723
139 Alzheimer's disease human IL-1 genes cluster PF 22498095
139 Alzheimer's disease human IL-1 genes cluster RF 22498095
140 Parkinson's Disease human IL-10 RF 21241672
140 Parkinson's Disease human IL-10 RF 22387064
141 Alzheimer's Disease human IL-12A PF TT genotype 25037175
142 Alzheimer's Disease human IL-12B PF GG genotype 25037175
142 Alzheimer's Disease human IL-12B PF GG/GT genotype 25037175
143 Parkinson's Disease human IL-18 RF 21241672
144 Alzheimer's disease human IL-1B RF 26768592
144 Alzheimer's disease human IL-1B RF 26768592
145 Alzheimer's disease human IL-1α RF 27014584
146 Multiple System Atrophy human IL-1β RF 29251119
147 Frontotemporal Lobar Degeneration human IMMP2L RF Discovery stage 30739198
148 Alzheimer's disease human insulin degrading enzyme gene (IDE) RF 20880607
148 Alzheimer's disease human insulin degrading enzyme gene (IDE) RF CC genotype was significantly associated with earlier age at onset 20880607
149 Amyotrophic Lateral Sclerosis human Intergenic RF The estimations using the proposed method (unadjusted estimates) 19740415
149 Amyotrophic Lateral Sclerosis human Intergenic RF The estimations using the proposed method (adjusted estimates) 19740415
150 Amyotrophic Lateral Sclerosis human Intergenic and SHROOM3 RF The estimations using the proposed method (unadjusted estimates) 19740415
151 Amyotrophic Lateral Sclerosis human Intergenic and SHROOM4 RF The estimations using the proposed method (adjusted estimates) 19740415
152 Frontotemporal Lobar Degeneration human IRF2 PF Discovery stage 30739198
153 Alzheimer’s Disease human ITGA4 RF Codominant; Genotype/Allele: AG; Univariate analysis 29769839
153 Alzheimer’s Disease human ITGA4 RF Dominant; Genotype/Allele: AG+GG; Univariate analysis 29769839
153 Alzheimer’s Disease human ITGA4 RF Dominant; Genotype/Allele: AG+GG; Multivariate analysis 29769839
153 Alzheimer’s Disease human ITGA4 RF Overdominant; Genotype/Allele: AG; Univariate analysis 29769839
153 Alzheimer’s Disease human ITGA4 RF Overdominant; Genotype/Allele: AG; Multivariate analysis 29769839
154 Amyotrophic lateral sclerosis human ITPR2 RF 25023141
155 Alzheimer's Disease human KCNJ15 RF 29432188
156 Alzheimer's disease human KIBRA PF 24190487
157 Amyotrophic lateral sclerosis human KIF5A RF 27455347
158 Alzheimer’s Disease human LCORL RF 29860282
159 Alzheimer's disease human LDLR RF 18065781
160 Alzheimer's disease human LHCGR PF carrying an APOE epsilon4 allele 18439297
161 Alzheimer's Disease human LOC100505811 RF 29027019
161 Alzheimer's Disease human LOC100505811 RF 29027019
161 Alzheimer's Disease human LOC100505811 RF 29027019
161 Alzheimer's Disease human LOC100505811 RF 29027019
162 Frontotemporal Lobar Degeneration human LOC101927354 RF Discovery stage 30739198
163 Amyotrophic Lateral Sclerosis human LOC107987057 RF 20801718
163 Amyotrophic Lateral Sclerosis human LOC107987057 RF 20801717
163 Amyotrophic Lateral Sclerosis human LOC107987057 RF In the joint analysis 20801717
164 Amyotrophic Lateral Sclerosis human LOC107987057,LOC112268043 RF 20801717
164 Amyotrophic Lateral Sclerosis human LOC107987057,LOC112268043 RF In the joint analysis 20801717
165 Amyotrophic Lateral Sclerosis human LOC112268043,LOC107987057 RF 20801718
166 Frontotemporal Lobar Degeneration human LOC730100 RF Minor allele:C 26154020
166 Frontotemporal Lobar Degeneration human LOC730100 RF Minor allele:G 26154020
166 Frontotemporal Lobar Degeneration human LOC730100 RF Minor allele:C 26154020
166 Frontotemporal Lobar Degeneration human LOC730100 RF Minor allele:T 26154020
166 Frontotemporal Lobar Degeneration human LOC730100 RF Minor allele:C 26154020
166 Frontotemporal Lobar Degeneration human LOC730100 RF Minor allele:A 26154020
166 Frontotemporal Lobar Degeneration human LOC730100 RF Minor allele:T 26154020
167 Alzheimer's disease human LRP2 RF 20971101
168 Multiple System Atrophy human LRRK2 RF 29480226
168 Parkinson's Disease human LRRK2 RF especially in early-onset patients 26234753
168 Parkinson's Disease human LRRK2 RF 23624603
168 Parkinson's Disease human LRRK2 PF 23115130
168 Parkinson's Disease human LRRK2 RF 23115130
168 Parkinson's Disease human LRRK2 RF 20629711
168 Parkinson's Disease human LRRK2 RF 21167764
168 Parkinson's Disease human LRRK2 RF 20673920
168 Parkinson's Disease human LRRK2 RF 19672984
168 Parkinson's Disease human LRRK2 RF 18201193
168 Parkinson's Disease human LRRK2 RF 18716801
168 Parkinson's Disease human LRRK2 RF 17960808
168 Parkinson's Disease human LRRK2 RF 17314670
168 Parkinson's Disease human LRRK2 RF 17019612
168 Parkinson's Disease human LRRK2 RF reater frequency of the G2019S mutation in Jewish than in non-Jewish cases with Parkinson disease 17050822
168 Parkinson's Disease human LRRK2 RF 16633828
168 Parkinson's Disease human LRRK2 RF 19854095
168 Parkinson's Disease human LRRK2 RF 19699188
169 Amyotrophic Lateral Sclerosis human M1(C/C) RF 17503480
170 Amyotrophic Lateral Sclerosis human M5(A/A) PF 17503480
171 Amyotrophic Lateral Sclerosis human M6(T/T) RF 17503480
172 Parkinson's Disease human MAO RF 7913737
172 Parkinson's Disease human MAO RF 7913737
173 Alzheimer's Disease human MAPT RF 22556362
173 Frontotemporal Dementia human MAPT RF a rare microtubule-associated protein tau (MAPT) sequence variant, c.454G>A (p.A152T) 23518664
173 Frontotemporal Dementia human MAPT RF 22556362
173 Frontotemporal Lobar Degeneration human MAPT RF H2H2 vs. H1H2 + H1H1 16410051
173 Frontotemporal Lobar Degeneration human MAPT RF 22556362
173 progressive supranuclear palsy human MAPT RF Meta-analysis 29986742
173 progressive supranuclear palsy human MAPT PF Meta-analysis 29986742
173 Parkinson's Disease human MAPT RF 19912324
173 Parkinson's Disease human MAPT RF 15627775
173 Multiple System Atrophy human MAPT RF H1 haplotype 21321341
174 progressive supranuclear palsy human MAPT H1c haplotype RF 28100725
175 Frontotemporal Dementia human MAPT H2 haplotype RF APOE e4 negatives 16410051
175 Frontotemporal Dementia human MAPT H2 haplotype RF 16410051
176 Frontotemporal Dementia human MAPT H2H3 genetype RF APOE e4 negatives 16410051
177 Alzheimer's disease human MC1R RF 28059796
177 Parkinson's Disease human MC1R RF 19194882
177 Parkinson's Disease human MC1R RF 19194882
178 Frontotemporal Lobar Degeneration human MFSD8 RF 30382371
179 Alzheimer's Disease human microtubule-associated protein tau (MAPT) gene PF individuals with a GG genotype of rs242557G/A 29098924
180 Alzheimer's Disease human MIEF1 RF 29177109
181 Frontotemporal Lobar Degeneration human MIR548AP RF Discovery stage 30739198
182 Alzheimer’s Disease human MLKL RF MLKL loss-of-function mutation 29656768
183 Amyotrophic lateral sclerosis human MOB3B RF 25023141
183 Amyotrophic Lateral Sclerosis human MOB3B RF 20801718
184 progressive supranuclear palsy human MOBP PF Meta-analysis 29986742
185 Alzheimer's Disease human mosaic aneuploidy in the brain RF 24602248
186 Alzheimer's disease human MS4A4E RF 26770425
187 Alzheimer’s Disease human MS4A6A RF Calculated by fixed effect model 29504051
187 Alzheimer’s Disease human MS4A6A RF Calculated by fixed effect model 29504051
187 Alzheimer’s Disease human MS4A6A RF Calculated by fixed effect model 29504051
187 Alzheimer's disease human MS4A6A PF 26770425
187 Alzheimer's disease human MS4A6A RF 22382309
188 Alzheimer's disease human MTHFD1L RF the results were influenced by APOE status 21741665
189 Alzheimer's Disease human MTHFR RF Genotype CT;P value adjusted for age, gender, educational attainment, and APOE-e4 status 25359311
189 Alzheimer's Disease human MTHFR RF AA genotype 23659764
189 Alzheimer's disease human MTHFR RF in APOE?4 or in non-APOE?4 carriers 28211809
189 Alzheimer's disease human MTHFR RF increased the odds of developing AD by 2.5 22015309
189 Alzheimer's disease human MTHFR RF without APOE epsilon4 alleles 20600372
190 Amyotrophic Lateral Sclerosis human MTHFR(T677T) RF 22385294
191 Amyotrophic Lateral Sclerosis human MTHFR(T677T/A1298A) RF 22385294
192 Alzheimer’s Disease human MTNR1A RF 29982836
193 Motor Neuron Disease human NEFH RF Genotype: SS 14722583
194 Amyotrophic lateral sclerosis human NEK1 RF 27455347
194 Amyotrophic lateral sclerosis human NEK1 RF 27455347
194 Amyotrophic lateral sclerosis human NEK1 RF 27455347
194 Amyotrophic lateral sclerosis human NEK1 RF 27455347
195 Alzheimer's disease human NEP gene (MME) RF 22493749
196 Alzheimer's disease human neprilysin (NEP) RF 20376800
197 Alzheimer's disease human NINJ2 PF 21674003
197 Alzheimer's disease human NINJ2 PF 21674003
197 Alzheimer's disease human NINJ2 PF 21674003
198 Amyotrophic Lateral Sclerosis human NIPA1 RF 22378146
199 Parkinson's Disease human NOD2 RF associated with late-onset PD 23651603
200 Frontotemporal Lobar Degeneration human NOS1 RF T allele 18042235
201 Alzheimer's disease human NOS3 RF 20505439
201 Alzheimer's disease human NOS3 RF in the APOE epsilon 4 noncarriers 18183499
201 Alzheimer's disease human NOS3 RF in the APOE epsilon 4 noncarriers 18183499
201 Frontotemporal Lobar Degeneration human NOS3 RF 19087148
202 Alzheimer's disease human NQO1 PF significant difference in the APOE epsilon4 non-carriers 18253865
202 Alzheimer's disease human NQO1 RF 18253865
203 Alzheimer’s Disease human NT-3 RF homozygotes or heterozygotes for the mutated type (Glu[-63]) 9502217
204 Alzheimer's disease human NTF-3 PF in patients lacking the ApoE-?4 allele 26814132
204 Alzheimer's disease human NTF-3 RF 24174922
204 Alzheimer's disease human NTF-3 RF 24174922
204 Alzheimer's disease human NTF-3 PF 24174922
205 Frontotemporal Lobar Degeneration human OLFM1 RF Discovery stage 30739198
206 Parkinson's Disease human Omi/HTRA2 RF 21338583
207 Alzheimer's disease human OX2R RF A allele may be a susceptible factor for AD 30955315
207 Alzheimer's disease human OX2R RF A allele may be a susceptible factor for AD 30955315
208 Alzheimer's disease human oxidized LDL receptor 1(OLR1) RF 21709374
208 Alzheimer's disease human oxidized LDL receptor 1(OLR1) RF 21709374
209 Parkinson's Disease human P2X7 RF 23648388
210 Amyotrophic lateral sclerosis human P4HB/PDIA1 RF 25913742
211 Parkinson's Disease human PARK16 PF 27174169
211 Parkinson's Disease human PARK16 RF 27174169
211 Parkinson's Disease human PARK16 RF 21419001
212 Parkinson's Disease human PARK2 RF 12056932
212 Parkinson's Disease human PARK2 RF 24729340
212 Parkinson's Disease human PARK2 RF 24729340
213 Parkinson's Disease human PARKIN RF 19636047
213 Parkinson's Disease human PARKIN RF 10511432
213 Parkinson's Disease human PARKIN RF 10511432
214 Tourette Syndrome human PARP1 RF CT versus TT 23576132
215 Tourette Syndrome human PARP2 PF 23576132
216 Parkinson's Disease human PD in first-degree relatives RF 11060508
217 Amyotrophic lateral sclerosis human PEAK1 RF 27455347
218 Alzheimer's disease human PEMT RF 21881829
219 Amyotrophic lateral sclerosis human PFN1 RF 24309268
220 Alzheimer’s Disease human PICALM RF PENN cohort 30128317
220 Alzheimer’s Disease human PICALM RF PENN cohort 30128317
220 Alzheimer's Disease human PICALM RF Genotype GG;P value adjusted for age, gender, educational attainment, and APOE-e4 status 25359311
221 Parkinson's Disease human PINK1 RF 16969854
221 Parkinson's Disease human PINK1 RF 27807026
222 Alzheimer's disease human PLA2G3 RF 20930276
223 Parkinson's Disease human PLA2G6 RF 22213678
224 Alzheimer's Disease human PLEKHG5 RF 29177109
225 Alzheimer’s Disease human PM20D1 PF in a particular genetic background 29736028
226 Hereditary Motor and Sensory Neuropathy human PMP22 RF 17p11.2 duplication 9183252
226 Hereditary Motor and Sensory Neuropathy human PMP22 RF 17p11.2 duplication 8179301
227 Amyotrophic Lateral Sclerosis human PON1 Q192R(major allele is Q) RF Recessive (RR vs other) 16822965
227 Amyotrophic Lateral Sclerosis human PON1 Q192R(major allele is Q) RF Additive 16822965
227 Amyotrophic Lateral Sclerosis human PON1 Q192R(major allele is Q) RF Dominant (RR and QR vs QQ) 16822965
228 Amyotrophic Lateral Sclerosis human PON2 C311S (major allele is S) RF Additive 16822965
228 Amyotrophic Lateral Sclerosis human PON2 C311S (major allele is S) RF Dominant (CC and CS vs SS) 16822965
229 Parkinson's Disease human positive family history of PD RF 9778597
230 Alzheimer's Disease human presence of one or more APOE ε4 alleles RF in females 26343475
231 Creutzfeldt-Jakob disease human PRNP RF APOE?ε4 carriers 21799773
231 Creutzfeldt-Jakob disease human PRNP RF BACE1?C-allele carriers 22952813
231 Creutzfeldt-Jakob disease human PRNP RF BACE1?C-allele carriers 22952813
231 Creutzfeldt-Jakob disease human PRNP RF Codon 129: Val homozygosity 8707291
231 Creutzfeldt-Jakob disease human PRNP RF 19081515
231 Creutzfeldt-Jakob disease human PRNP RF 19081515
231 Creutzfeldt-Jakob disease human PRNP RF 22210626
232 Alzheimer’s Disease human PS-1 RF 8930979
232 Alzheimer’s Disease human PS-1 RF 9298817
232 Alzheimer’s Disease human PS-1 RF APOE ε4 10581373
233 Alzheimer’s Disease human PS-2 RF APOE ε4 10581373
234 Alzheimer's Disease human PSEN1 RF 25104557
234 Lewy body dementia human PSEN1 RF 27312774
235 Alzheimer's Disease human PSEN2 RF 25104557
235 Alzheimer's Disease human PSEN2 RF 24927704
236 Alzheimer’s Disease human PTK2B PF National Alzheimer’s Coordinating Center (NACC) cohort 30128317
237 Alzheimer’s Disease human PVRL2 RF eQTL(expression quantitative trait loci) analysis for the five SNPs closely related to AD 30319691
237 Alzheimer’s Disease human PVRL2 RF eQTL(expression quantitative trait loci) analysis for the five SNPs closely related to AD 30319691
237 Alzheimer’s Disease human PVRL2 RF eQTL(expression quantitative trait loci) analysis for the five SNPs closely related to AD 30319691
237 Alzheimer's Disease human PVRL2 RF using logistic regression、Dataset：CHS( Cardiovascular Health Study) 29107063
237 Alzheimer's Disease human PVRL2 RF using logistic regression、Dataset：HRS(Health and Retirement Study) 29107063
237 Alzheimer's Disease human PVRL2 RF using logistic regression、Dataset：LOADFS(Late Onset Alzheimer's Disease Family Study ) 29107063
237 Alzheimer's Disease human PVRL2 RF using Cox regression、Dataset：CHS（Cardiovascular Health Study） 29107063
238 Alzheimer's Disease human RAB10 PF 29183403
239 Alzheimer's Disease human RCAN1 RF 26497675
239 Alzheimer's Disease human RCAN1 RF 26497675
240 Alzheimer's Disease human reduced DYRK1A expression RF 25116835
241 Alzheimer's disease human reduced folate carrier gene (RFC1) RF especially for female individuals 18258338
241 Alzheimer's disease human reduced folate carrier gene (RFC1) RF especially for female individuals 18258338
242 Frontotemporal Lobar Degeneration human RERG PF Discovery stage 30739198
243 Parkinson's Disease human Saitohin PF 25168738
243 Parkinson's Disease human Saitohin RF 25168738
244 Multiple System Atrophy human SCA1 RF 29715545
245 Multiple System Atrophy human SCA3 RF 17133518
246 Parkinson's Disease human SEMA5A PF 18950607
246 Parkinson's Disease human SEMA5A PF 18950607
246 Parkinson's Disease human SEMA5A RF 18950607
246 Parkinson's Disease human SEMA5A RF 18950607
246 Parkinson's Disease human SEMA5A PF 24706317
247 Alzheimer's disease human SERPINE1 RF women were at an increased risk over their male genotype counterparts 28466654
247 Alzheimer's disease human SERPINE1 RF women were at an increased risk over their male genotype counterparts 28466654
248 Alzheimer's disease human SHARPIN RF 31216982
249 Alzheimer's disease human SIRT2 RF APOEε4 noncarriers 24139700
249 Alzheimer's disease human SIRT2 RF 24139700
250 Parkinson's Disease human SLC6A3 RF 24211691
250 Parkinson's Disease human SLC6A3 RF 24211691
250 Parkinson's Disease human SLC6A3 RF 24211691
250 Parkinson's Disease human SLC6A3 RF 24211691
250 Parkinson's Disease human SLC6A3 PF 24211691
251 Alzheimer’s Disease human SLC6A4/5-HTT PF S allele; AD with depression 29703883
252 progressive supranuclear palsy human SLCO1A2 PF Meta-analysis 29986742
253 Amyotrophic Lateral Sclerosis human SMN1 RF one copy 16931506
253 Amyotrophic Lateral Sclerosis human SMN1 RF three copies 16931506
253 Amyotrophic Lateral Sclerosis human SMN1 RF one or three copies of SMN1 gene were pooled 16931506
253 Amyotrophic Lateral Sclerosis human SMN1 RF abnormal SMN1 copy numbers 19922137
254 Amyotrophic Lateral Sclerosis human SMN2 RF 22187232
255 Parkinson's Disease human SMPD1 RF 26169695
255 Parkinson's Disease human SMPD1 RF 23535491
256 Lewy body dementia human SNCA PF 29263008
256 Parkinson's Disease human SNCA RF 27699750
256 Parkinson's Disease human SNCA RF 22349157
256 Parkinson's Disease human SNCA RF 18404644
256 Parkinson's Disease human SNCA RF 18404644
257 Amyotrophic Lateral Sclerosis human SOD1 RF Expression of N19S-SOD1, an SOD1 Mutant 16035108
257 Amyotrophic lateral sclerosis human SOD1 RF 24591609
258 Alzheimer's Disease human SOD1 gene PF After Bonferroni correction；recessive model 25440013
258 Alzheimer's Disease human SOD1 gene PF After Bonferroni correction；additive model 25440013
258 Alzheimer's Disease human SOD1 gene PF Logistic regression analysis controlled for age, genderand APOE carrier status；recessive model 25440013
258 Alzheimer's Disease human SOD1 gene PF Logistic regression analysis controlled for age, genderand APOE carrier status；additive model 25440013
259 Alzheimer's Disease human SORL1 RF with the A allele 25450149
259 Alzheimer’s Disease human SORL1 PF 30009200
259 Alzheimer's Disease human SORL1 RF 26303663
259 Alzheimer's Disease human SORL1 RF when restricting the analysis to the 205 cases with a positive family history 26303663
259 Alzheimer's Disease human SORL1 RF adjusted for age and gender 25881907
259 Alzheimer's Disease human SORL1 RF adjusted foe age, gender, APOE 4 25881907
259 Alzheimer's Disease human SORL1 RF 19368828
259 Alzheimer's disease human SORL1 RF 24486888
259 Alzheimer's disease human SORL1 PF 18407551
260 Alzheimer's disease human SORT1 PF 27392867
261 Amyotrophic Lateral Sclerosis human SPG4 RF 16009903
262 Amyotrophic lateral sclerosis human SQSTM1 RF 22972638
263 Alzheimer’s Disease human SREBF2 RF significant dual associations with LOAD pathological biomarkers and gene expression levels 29503034
264 Alzheimer's Disease human SRR RF 29338921
265 Alzheimer's disease human STARD6 RF in combination with the APOE ε4 allele 30666118
266 Alzheimer's disease human STH RF especially in caucasian population, late‐onset AD subjects and studies with high quality 28211174
267 Parkinson's Disease human STK39 RF 26469904
268 Amyotrophic lateral sclerosis human STX12 RF 27455347
269 progressive supranuclear palsy human STX6 PF Meta-analysis 29986742
270 Alzheimer's disease human SUMO1 RF 27084229
271 Alzheimer's disease human SUMO2 RF 27084229
271 Alzheimer's disease human SUMO2 RF 27084229
272 Amyotrophic lateral sclerosis human SUN3, HUS1 RF 25023141
273 Alzheimer’s Disease human SYMPK RF eQTL(expression quantitative trait loci) analysis for the five SNPs closely related to AD 30319691
274 Amyotrophic lateral sclerosis human TARDBP RF 25023141
274 Frontotemporal Lobar Degeneration human TARDBP RF 18505686
274 Frontotemporal Lobar Degeneration human TARDBP RF heterozygous c.876_878delCAG 22892647
275 Frontotemporal Lobar Degeneration human tau RF tau Genotype:H1H1;absence of APOE E2 allele 12056929
275 Frontotemporal Lobar Degeneration human tau RF tau Genotype:H1H2+H2H2;presence of APOE E2 allele 12056929
276 progressive supranuclear palsy human tau A0/A0 genotype RF 9708963
278 Frontotemporal Lobar Degeneration human tau,APOE RF tau A3,APOE ε4 11303757
279 Alzheimer's disease human TFAM RF 18430995
279 Parkinson's Disease human TFAM RF 19925850
280 Alzheimer's Disease human TGF-β1 RF Genotype AC 26327336
280 Alzheimer's Disease human TGF-β1 RF allele C 26327336
280 Alzheimer's Disease human TGF-β1 RF Genotype TG 26327336
280 Alzheimer's Disease human TGF-β1 RF allele G 26327336
280 Alzheimer's Disease human TGF-β1 RF without the ApoE ε4 allele;AC 26327336
280 Alzheimer's Disease human TGF-β1 RF without the ApoE ε4allele;C 26327336
280 Alzheimer's Disease human TGF-β1 RF without the ApoE ε4 allele;TG 26327336
280 Alzheimer's Disease human TGF-β1 RF without the ApoE ε4 allele;G 26327336
280 Alzheimer's Disease human TGF-β1 RF AC+ CC vs AA 26327336
281 Parkinson's Disease human TH RF 20809526
282 Alzheimer's Disease human THBS2 RF 29177109
283 Lewy body dementia human The apolipoprotein E (APOE) ε4 allele RF 21552550
284 Amyotrophic lateral sclerosis human TIAM1 RF 25023141
284 Amyotrophic Lateral Sclerosis human TIAM1 RF 20801718
285 Alzheimer's disease human TLR2 PF 26738351
286 Alzheimer's disease human TLR4 PF when incorporated into a haplotype with rs10759930, the strongest association was detected 22272615
287 Alzheimer's disease human TMEM106B RF APOE interact 24166182
287 Frontotemporal Dementia human TMEM106B PF C9ORF72 expansion carriers;Cohort 1 – controls and C9ORF72 repeat expansion carriers (FTD, FTD/MND, and MND, or other diagnosis) 24385136
287 Frontotemporal Dementia human TMEM106B PF C9ORF72 expansion carriers;Cohort 1 – controls and C9ORF72 repeat expansion carriers (FTD, FTD/MND, and MND, or other diagnosis) 24385136
287 Frontotemporal Lobar Degeneration human TMEM106B PF GRN carriers 25085782
287 Frontotemporal Lobar Degeneration human TMEM106B PF for SNPs on chromosomes 1, 8, 10 and 11 genotyped 21257233
287 Frontotemporal Lobar Degeneration human TMEM106B RF for chromosome 1 SNP association 21257233
287 Frontotemporal Lobar Degeneration human TMEM106B RF for chromosome 1 SNP association 21257233
287 Frontotemporal Lobar Degeneration human TMEM106B RF for chromosome 9 SNP association 21257233
287 Frontotemporal Lobar Degeneration human TMEM106B RF for chromosome 9 SNP association 21257233
287 Frontotemporal Lobar Degeneration human TMEM106B RF for chromosome 9 SNP association 21257233
287 Frontotemporal Lobar Degeneration human TMEM106B RF for chromosome 9 SNP association 21257233
287 Frontotemporal Lobar Degeneration human TMEM106B RF for chromosome 9 SNP association; Denotes the associated SNP’s from the FTLD-TDP GWAS. 21257233
287 Frontotemporal Lobar Degeneration human TMEM106B RF for chromosome 9 SNP association; Denotes the associated SNP’s from the FTLD-TDP GWAS. 21257233
287 Frontotemporal Lobar Degeneration human TMEM106B RF for chromosome 9 SNP association; Denotes the associated SNP’s from the FTLD-TDP GWAS;Denotes the associated SNP’s from the ALS GWAS 21257233
287 Frontotemporal Lobar Degeneration human TMEM106B RF for chromosome 9 SNP association; Denotes the associated SNP’s from the FTLD-TDP GWAS. 21257233
287 Frontotemporal Lobar Degeneration human TMEM106B RF for chromosome 9 SNP association 21257233
287 Frontotemporal Lobar Degeneration human TMEM106B RF for chromosome 9 SNP association 21257233
288 Alzheimer's disease human TMP21 RF 28233271
289 Alzheimer's disease human TNFRSF1A, CDH1, CASP7, LRP1B and TG RF 26621834
290 Alzheimer's disease human TNF-α RF in the APOE epsilon4 non-carriers 18396294
290 Alzheimer's disease human TNF-α RF in the APOE epsilon4 non-carriers 18396294
290 Multiple System Atrophy human TNF-α RF genotype 29251119
290 Multiple System Atrophy human TNF-α RF allele 29251119
291 Alzheimer's Disease human TNF-α -308 RF A vs. G allele 25647294
291 Alzheimer's Disease human TNF-α -308 RF AA + AG vs. GG (dominant) 25647294
291 Alzheimer's Disease human TNF-α -308 RF AA vs. AG + GG (recessive) 25647294
291 Alzheimer's Disease human TNF-α -308 RF AA vs. GG 25647294
291 Alzheimer's Disease human TNF-α -308 RF AA vs. AG 25647294
292 Alzheimer’s Disease human TOMM40 RF 29797398
292 Alzheimer’s Disease human TOMM40 RF 29797398
292 Alzheimer's Disease human TOMM40 RF using logistic regression、Dataset：CHS( Cardiovascular Health Study) 29107063
292 Alzheimer's Disease human TOMM40 RF using logistic regression、Dataset：FHS(Framingham Heart Study) 29107063
292 Alzheimer's Disease human TOMM40 RF using logistic regression、Dataset：HRS(Health and Retirement Study) 29107063
292 Alzheimer's Disease human TOMM40 RF using logistic regression、Dataset：HRS(Health and Retirement Study) 29107063
292 Alzheimer's Disease human TOMM40 RF using logistic regression、Dataset：HRS(Health and Retirement Study) 29107063
292 Alzheimer's Disease human TOMM40 RF using logistic regression、Dataset：LOADFS(Late Onset Alzheimer's Disease Family Study ) 29107063
292 Alzheimer's Disease human TOMM40 RF using Cox regression、Dataset：CHS（Cardiovascular Health Study） 29107063
292 Alzheimer's Disease human TOMM40 RF using Cox regression、Dataset：FHS（Framingham Heart Study） 29107063
292 Alzheimer's Disease human TOMM40 RF using Cox regression、Dataset：HRS（Health and Retirement Study） 29107063
292 Alzheimer's Disease human TOMM40 RF using Cox regression、Dataset：HRS（Health and Retirement Study） 29107063
292 Alzheimer's disease human TOMM40 RF 30443289
292 Alzheimer's disease human TOMM40 RF the association between the Asian and Caucasian groups was significantly different 26795201
292 Alzheimer's disease human TOMM40 PF the association between the Asian and Caucasian groups was significantly different 26795201
293 Alzheimer’s Disease human TREM2 RF 30222607
293 Alzheimer’s Disease human TREM2 RF 29794134
293 Alzheimer's Disease human TREM2 RF 26037549
293 Alzheimer's Disease human TREM2 RF 25936935
293 Alzheimer's Disease human TREM2 RF the T allele of the rs75932628 variant of TREM2 25260849
293 Alzheimer's Disease human TREM2 RF 25160042
293 Alzheimer's disease human TREM2 RF 24439484
293 Alzheimer's disease human TREM2 RF 24041969
293 Alzheimer's disease human TREM2 RF 24041969
293 Alzheimer's disease human TREM2 RF 23855982
293 Amyotrophic lateral sclerosis human TREM2 RF 24535663
293 Frontotemporal Dementia human TREM2 RF 29557178
293 Frontotemporal Dementia human TREM2 RF 23800361
293 Frontotemporal Lobar Degeneration human TREM2 RF 24139279
293 Frontotemporal Lobar Degeneration human TREM2 RF A large consanguineous Colombian family segregating autosomal recessive FTLD 23582655
293 Frontotemporal Lobar Degeneration human TREM2 RF Compound heterozygosity 29557178
293 Frontotemporal Lobar Degeneration human TREM2 RF 29557178
293 Frontotemporal Lobar Degeneration human TREM2 RF Compound heterozygosity 29557178
293 Frontotemporal Lobar Degeneration human TREM2 RF 29557178
293 Frontotemporal Lobar Degeneration human TREM2 RF Homozygosity 29557178
293 Frontotemporal Lobar Degeneration human TREM2 RF 23800361
293 Frontotemporal Lobar Degeneration human TREM2 RF T vs. C 29322490
293 Frontotemporal Lobar Degeneration human TREM2 RF CT vs. CC 29322490
293 Frontotemporal Lobar Degeneration human TREM2 RF CT+TT vs. CC 29322490
293 Frontotemporal Lobar Degeneration human TREM2 RF carrier T vs. C 29322490
293 Frontotemporal Lobar Degeneration human TREM2 RF T vs. G 29322490
293 Frontotemporal Lobar Degeneration human TREM2 RF GT vs. GG 29322490
293 Frontotemporal Lobar Degeneration human TREM2 RF GT+TT vs. GG 29322490
293 Frontotemporal Lobar Degeneration human TREM2 RF carrier T vs. G 29322490
293 Dementia with Lewy bodies human TREM2 RF 28003435
293 Parkinson's Disease human TREM2 RF 23800361
293 Alzheimer's Disease human TREM2 RF 23380991
294 Multiple System Atrophy human TREM2 p.R47H RF patients with pathologically confirmed MSA 30109269
294 Multiple System Atrophy human TREM2 p.R47H RF patients with clinically diagnosed MSA 30109269
294 Multiple System Atrophy human TREM2 p.R47H RF patients with pathologically confirmed MSA 30109269
294 Multiple System Atrophy human TREM2 p.R47H RF patients with clinically diagnosed MSA 30109269
295 Alzheimer's disease human TREML2 PF 24439484
296 Alzheimer's disease human TYROBP RF 27658901
297 Frontotemporal Lobar Degeneration human UBAP1 RF Haplotype:TGC 19217189
297 Frontotemporal Lobar Degeneration human UBAP1 RF Haplotype:TGC 19217189
297 Frontotemporal Lobar Degeneration human UBAP1 RF Haplotype:GCT 19217189
298 Alzheimer's disease human ubiquilin 1 gene (UBQLN1) RF This effect was stronger in a group of LOAD patients without APOE4 allele 18340109
299 Parkinson's Disease human UCHL1 RF 22839974
300 Amyotrophic Lateral Sclerosis human UNC12A RF 22118904
301 Amyotrophic lateral sclerosis human UNC13A RF especially in Caucasian and European subjects 31201598
301 Amyotrophic Lateral Sclerosis human UNC13A RF 22118904
301 Frontotemporal Lobar Degeneration human UNC13A RF Discovery stage 30739198
301 Frontotemporal Lobar Degeneration human UNC13A RF Replication stage 30739198
302 Amyotrophic lateral sclerosis mouse VAPB RF 23446633
302 Amyotrophic lateral sclerosis zebrafish VAPB RF 23446633
303 Frontotemporal Lobar Degeneration human VEGF RF A allele 18729809
303 Frontotemporal Lobar Degeneration human VEGF RF A allele 18729809
303 Parkinson's Disease human VEGF RF 27481110
304 progressive supranuclear palsy human VEGF haplotypes(AGG) RF 20413880
305 Parkinson's Disease human VMAT2 RF 27137201
306 Amyotrophic lateral sclerosis human WDR49 RF 27455347
307 Amyotrophic lateral sclerosis human ZSCAN5B RF 27455347
191 Amyotrophic Lateral Sclerosis Human MTHFR(T677T/A1298A) RF 22385294
52 Alzheimer's disease human CD33 RF 31611055
903 Tourette syndrome (TS) human CNR 1 RF 32753051
178 Amyotrophic lateral sclerosis human MFSD8 RF 32485802
904 Parkinson's Disease human Monoamine?oxidase-B?(MAO-B) RF levodopa-induced dyskinesia(LID) 32979926
905 Tourette syndrome (TS) human PCNT RF 32979926
905 Tourette syndrome (TS) human PCNT RF 32979926
905 Tourette syndrome (TS) human PCNT RF 32979926
15 Alzheimer's disease human APOE RF 32979926
15 Alzheimer's disease human APOE RF 32979926
15 Alzheimer's disease human APOE RF 32979926
15 Alzheimer's disease human APOE RF 32979926
27 Parkinson's Disease human ATP10B RF recessive loss of function mutations 33177243
44 Amyotrophic lateral sclerosis human C9orf72 RF 33177243
44 Amyotrophic lateral sclerosis human C9orf72 RF 33177243
906 Amyotrophic lateral sclerosis human CACNA1H RF 33177243
907 Creutzfeldt-Jakob disease human Cerebroside sulfotransferase (GAL3ST1) RF 32870568
908 Creutzfeldt-Jakob disease human GAL3ST1 RF 32625160
909 Parkinson's Disease human GP1BA RF 32625160
910 Parkinson's Disease human GP6 RF 32625160
122 Frontotemporal Lobar Degeneration human GRN RF FTLD with TAR DNA-binding protein (TDP-43) inclusions 32625160
122 Frontotemporal dementia human GRN RF in CC homozygous patients 32946420
912 Alzheimer's disease human Ig γ marker (GM) allotypes RF encoded by highly polymorphic IGHG genes on chromosome 14q32 33006184
913 Parkinson's Disease human ITGB5 RF 33006184
914 Amyotrophic lateral sclerosis human LRP10 RF rare, pathogenic variants in LRP10 33006184
915 Parkinson's Disease human P2RY12 RF 32687038
231 Creutzfeldt-Jakob disease human PRNP RF 33138082
916 Amyotrophic lateral sclerosis human SPG7 mutations RF 33138082
917 Creutzfeldt-Jakob disease human STX6(Syntaxin-6) RF 33138082
917 Creutzfeldt-Jakob disease human STX6(Syntaxin-6) RF 33138082
287 Frontotemporal Lobar Degeneration human TMEM106B RF FTLD with TAR DNA-binding protein (TDP-43) inclusions 33138082
918 Frontotemporal dementia human TP53 RF 33138082
919 Amyotrophic lateral sclerosis human intermediate-length alleles when present in both alleles RF Carriership of two intermediate-length alleles was associated with ALS, when the longer allele was ≥ 17 repeats 33021140
919 Amyotrophic lateral sclerosis human intermediate-length alleles when present in both alleles RF Carriership of two intermediate-length alleles was associated with ALS, when the longer allele was ≥ 21 repeats 33021140
logo
All rights reserved: Institutes for Systems Genetics, West China Hospital